Great panel on preferred instruments and surgical techniques. Pictured here: Kyle D. Kovacs, MD; James Klancnik, MD; Talia R. Kaden, MD; Gaetano R. Barile, MD; Kenneth J. Wald, MD; and Audina M. Berrocal, MD (moderator). #ACRC2024 #Retina #Macula2024

A patient presented with an episode of toxoplasma choroiditis…two years later he presented with similar findings, but this time repeat testing by Naomi Goldberg, MD, PhD, revealed it was syphilis. #ACRC2024 #Retina

Jaclyn L. Kovach, MD, wrapped up the second day of #ACRC2024 with a case of sorsby fundus dystrophy masquerading as AMD. #Retina

Double circumferential rings of traction in a whole family with myopia helped Nimesh A. Patel, MD, diagnose Wagner syndrome. #ACRC2024 #Retina

Next up, Linda McKie takes us through ecologies of care

#acrc2024

Gene therapy is happening now, and it’s time to pay attention in retina, according to Allen C. Ho, MD. Last month (Dec. 8, to be exact), a CRISPR exa-cel therapy was approved for sickle cell disease. Gene therapy for wet AMD is in phase 3 too. #ACRC2024 #Retina #Macula2024

David Sarraf, MD, discussed his team’s recent findings related to dot, ribbon, and soft drusen, suggesting a trizonal pattern in 31 of 33 eyes (94%). #ACRC2024 #Retina #Macula2024

The Pathhead Choir close our first day with some songs created as part of research into songwriting for older adults. #ACRC2024

Looking for evidence of amyloid in the eye? Check the choriocapillaris band on OCT, according to Anita Agarwal, MD. #ACRC2024 #Retina #Macula2024

We're getting ready to welcome everyone to our Spring Symposium, follow along with #ACRC2024

Great talk on adult-onset foveomacular vitelliform dystrophy (AFVD). Itay Chowers, MD, suggested a possible overlap between AMD and AFVD via the complement cascade. #ACRC2024 #Retina #Macula2024

Tamara L. Lenis, MD, PhD, used a case of malignant melanoma treated with pembrolizumab to showcase the potential retinal side effects of immunotherapy. #ACRC2024 #Retina

Congratulations to the 2024 Founders Award honorees Susan B. Bressler, MD; Alexander J. Brucker, MD; and Richard B. Rosen, MD!! #ACRC2024 #Retina #Macula2024

Nadia K. Waheed, MD, MPH, shared her imaging findings in patients treated with gene therapy, including signs of inflammation, atrophy, and retinotomy-related, outer retina, and pigmentary changes. #ACRC2024 #Retina #Macula2024

Nan-Kai Wang, MD, PhD, shared a wonderful case of neuronal intranuclear inclusion disease in a family, all of whom had negative WES testing. Dr. Wang had to repeat testing specific for GGC. #ACRC2024 #Retina

'We are all going to grow older, some of us, some of us sooner rather than later'.

Our #ACRC2024 lay address comes from Peter Smith, a member of the ACRC Public and Patient Involvement Group.

Amani A. Fawzi, MD, and her team looked at double-layer signs in fovea-sparing GA and found the presence of a thick double-layer sign in the foveal area may play a protective role. #ACRC2024 #Retina #Macula2024

Christine A. Curcio, PhD, adds to our understanding of RPE lipofuscin and autofluorescence. Perhaps RPE lipofuscin/fluorophores are essential, regulated components of retinoid balance? #ACRC2024 #Retina #Macula2024

Anat Loewenstein, MD, MHA, demonstrates the utility of home-OCT guided management of wet AMD. Protocol AO looking at home-OCT in naïve wet AMD patients is enrolling. #ACRC2024 #Retina #Macula2024

Experts discussed how they choose the right drug for patients with wet AMD. Pictured here: Nicolas A. Yannuzzi, MD; Carl D. Regillo, MD; David M. Brown, MD, FACS; Michael J. Cooney, MD, MBA; and Marco A. Zarbin, MD, PhD (moderator). #ACRC2024 #Retina #Macula2024